Abstract
The management of patients presenting with metastatic malignant melanoma (MM) is hampered by the substantial variability in survival of these patients and the lack of prognostic markers. In the search for a reliable predictive parameter, we have investigated the expression of the nm23 gene, considered to be a major regulator of the metastatic process. We have analysed by Northern blot the nm23 mRNA level in tumour tissue obtained from metastases of 20 stage II and ten stage III patients with MM. Normal human tissues and benign naevi were simultaneously examined. The level of nm23 expression was highly heterogeneous in MM metastases, with a mean value which was higher than the mean level in normal tissues and naevi. Correlative study was focused on the overall survival following resection of the metastasis in which nm23 Northern blot analysis was performed. Patients displaying higher nm23 expression in metastatic tissue (above the mean level) tended to have a longer survival than others (P = 0.08), and this difference was significant for patients presenting with isolated regional lymph node involvement (P = 0.035). The time from biopsy of the primary MM to the appearance of the first lymph node metastasis also showed a positive correlation with the nm23 mRNA level in this metastasis. The present study is not only in accordance with previous reports showing that the nm23 gene may be implicated in MM progression, but also suggests the reliable value of nm23 expression as a prognostic marker for patients presenting with metastatic MM.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xerri, L., Grob, JJ., Battyani, Z. et al. NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Br J Cancer 70, 1224–1228 (1994). https://doi.org/10.1038/bjc.1994.477
Issue Date:
DOI: https://doi.org/10.1038/bjc.1994.477
This article is cited by
-
Mechanisms of action of NME metastasis suppressors – a family affair
Cancer and Metastasis Reviews (2023)
-
The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis
Pathology & Oncology Research (2020)
-
NDPKA is not just a metastasis suppressor – be aware of its metastasis-promoting role in neuroblastoma
Laboratory Investigation (2018)
-
Metastasis-suppressor genes in clinical practice: lost in translation?
Nature Reviews Clinical Oncology (2011)
-
Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression
Cancer Cell International (2008)